Obesity: a challenge for science and society

Valentin Fuster

doi:10.1038/ncpcardio0070 | Full Text | PDF (62K)

Pharmacogenetics: the outlook for genetic testing in statin therapy

Daniel I Chasman and Paul M Ridker

doi:10.1038/ncpcardio0071 | Full Text | PDF (94K)

New evidence on atenolol in hypertension

doi:10.1038/ncpcardio0080 | Full Text | PDF (72K)

ACE inhibition shows no benefit in the PEACE trial

doi:10.1038/ncpcardio0081 | Full Text | PDF (72K)

A-HeFT trial: positive results

doi:10.1038/ncpcardio0082 | Full Text | PDF (79K)

CAMELOT trial shows benefit of amlodipine

doi:10.1038/ncpcardio0083 | Full Text | PDF (80K)

Advances in infant heart transplantation

doi:10.1038/ncpcardio0084 | Full Text | PDF (86K)

-blockers in hypertensive patients with diabetes mellitus

doi:10.1038/ncpcardio0085 | Full Text | PDF (88K)

Warfarin therapy in patients with atrial fibrillation: risk of intracranial hemorrhage

doi:10.1038/ncpcardio0086 | Full Text | PDF (88K)

Community-based screening for abdominal aortic aneurysm

doi:10.1038/ncpcardio0087 | Full Text | PDF (66K)

Role of the leukocyte count in CHD risk assessment

doi:10.1038/ncpcardio0088 | Full Text | PDF (66K)

Specialized management for low-risk heart failure patients

doi:10.1038/ncpcardio0089 | Full Text | PDF (73K)

Body-mass index in secondary prevention

doi:10.1038/ncpcardio0090 | Full Text | PDF (66K)

Lack of consensus on preoperative cardiac risk management

doi:10.1038/ncpcardio0091 | Full Text | PDF (73K)

Electrocardiographic diagnosis of atrial fibrillation

doi:10.1038/ncpcardio0092 | Full Text | PDF (66K)

Prophylaxis of patent ductus arteriosus: two studies of ibuprofen

doi:10.1038/ncpcardio0093 | Full Text | PDF (66K)

Does intensive statin therapy lower mortality and cardiovascular event risk in patients with acute coronary syndrome?

Steven E Nissen

doi:10.1038/ncpcardio0066 | Full Text | PDF (92K)

Fetal echocardiography: can early imaging identify fetuses at risk of congenital heart disease?

Mark Sklansky

doi:10.1038/ncpcardio0067 | Full Text | PDF (93K)

Should elderly heart failure patients be treated with -blockade therapy?

Karl Swedberg

doi:10.1038/ncpcardio0077 | Full Text | PDF (98K)

Should pacemakers be removed in the event of localized implantation-site infection?

Anil Gehi and Davendra Mehta

doi:10.1038/ncpcardio0076 | Full Text | PDF (93K)

Can aortic atherosclerotic plaques predict cerebrovascular and cardiac events?

Jean-François Toussaint

doi:10.1038/ncpcardio0079 | Full Text | PDF (94K)

Is the risk of sudden death and nonfatal cardiac arrest reduced by ACE inhibitor therapy?

Lars Kjøller-Hansen

doi:10.1038/ncpcardio0072 | Full Text | PDF (93K)

Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing

David P Faxon

doi:10.1038/ncpcardio0065 | Full Text | PDF (205K)

Cell therapy for cardiovascular disease: what cells, what diseases and for whom?

Noel M Caplice, Bernard J Gersh and Jorge R Alegria

doi:10.1038/ncpcardio0073 | Full Text | PDF (129K)

The sinus tachycardias

Shamil Yusuf and A John Camm

doi:10.1038/ncpcardio0068 | Full Text | PDF (681K)

Reversible cardiomyopathy caused by administration of interferon

Aarif Y Khakoo, Marc K Halushka, J Eduardo Rame, E Rene Rodriguez, Edward K Kasper and Daniel P Judge

doi:10.1038/ncpcardio0069 | Full Text | PDF (364K)